Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: A prospective clinical study

Influence of Previous Use of Inhaled Corticoids on the Development of Pleural Effusion in Community-acquired Pneumonia

(2013) Jacobo Sellares et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effects of Inhaled Corticosteroids on Pneumonia Severity and Antimicrobial Resistance

(2013) O. Sibila et al.   Respiratory Care

Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting  2 agonist: observational matched cohort study (PATHOS)

(2013) C. Janson et al.   BMJ-British Medical Journal

Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells

(2012) Mutsuo Yamaya et al.   EUROPEAN RESPIRATORY JOURNAL

Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with Pneumonia

(2011) Dennis Chen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Strange Case of Community-Acquired Pneumonia in COPD

(2011) Antoni Torres et al.   CHEST

Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients

(2011) A. Liapikou et al.   EUROPEAN RESPIRATORY JOURNAL

Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia

(2011) A. Singanayagam et al.   EUROPEAN RESPIRATORY JOURNAL

Reported Pneumonia in Patients With COPD

(2010) Peter M.A. Calverley et al.   CHEST

Systemic cytokine response in patients with community-acquired pneumonia

(2010) H. Endeman et al.   EUROPEAN RESPIRATORY JOURNAL

Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia

(2010) R. Malo de Molina et al.   EUROPEAN RESPIRATORY JOURNAL

Long-term Use of Inhaled Corticosteroids and the Risk of Pneumonia in Chronic Obstructive Pulmonary Disease

(2009) Sonal Singh et al.   ARCHIVES OF INTERNAL MEDICINE

Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus

(2009) C. L. Skevaki et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Macrophage activation in exacerbated COPD with and without community-acquired pneumonia

(2009) P. Gutierrez et al.   EUROPEAN RESPIRATORY JOURNAL

Defective macrophage phagocytosis of bacteria in COPD

(2009) A. E. Taylor et al.   EUROPEAN RESPIRATORY JOURNAL

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

(2009) S Ewig et al.   THORAX

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

(2009) R Menendez et al.   THORAX

The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study

(2009) S.F. Paul Man et al.   Therapeutic Advances in Respiratory Disease

Corticosteroids in severe pneumonia

(2008) O. Sibila et al.   EUROPEAN RESPIRATORY JOURNAL

Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease

(2008) M. Bradley Drummond et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Macrophage activation and polarization

(2007) Fernando Oneissi Martinez   Frontiers in Bioscience-Landmark